MARKET

AVXL

AVXL

Anavex Life Scie
NASDAQ
3.105
-0.105
-3.27%
Opening 10:54 08/18 EDT
OPEN
3.160
PREV CLOSE
3.210
HIGH
3.205
LOW
3.105
VOLUME
69.98K
TURNOVER
--
52 WEEK HIGH
10.40
52 WEEK LOW
2.255
MARKET CAP
287.82M
P/E (TTM)
-6.6789
1D
5D
1M
3M
1Y
5Y
1D
Press Release: Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees
Dow Jones · 1d ago
Weekly Report: what happened at AVXL last week (0810-0814)?
Weekly Report · 1d ago
Anavex Life Sciences Mails Letter to Stockholders Reinforcing Relevant Experience of All Six Director Nominees
Barchart · 1d ago
Anavex Life Sciences Files Proxy, Urges Director Support
TipRanks · 6d ago
*Anavex Life Sciences: PVG's Nominees Lack Critical Drug Development and Regulatory Expertise >AVXL
Dow Jones · 08/11 12:10
Anavex Life Sciences Delays Quarterly SEC Filing
TipRanks · 08/10 23:09
Weekly Report: what happened at AVXL last week (0803-0807)?
Weekly Report · 08/10 10:02
Anavex Life Sciences refreshes board with two new independent director nominees
Seeking Alpha · 08/03 13:09
More
About AVXL
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with high unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which it uses in the analysis of its clinical trials. Its focus is on developing treatments for Alzheimer’s disease, Parkinson’s disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other CNS disorders. Its pipeline products include ANAVEX 2-73 (blarcamesine) and ANAVEX 3-7. Its other programs include ANAVEX 1-41, ANAVEX 1066 and ANAVEX 1037. ANAVEX 2-73 is being developed as well as an oral once-daily capsule formulation for diseases such as Alzheimer’s disease and Parkinson’s disease, and in an oral liquid once-daily formulation for rare diseases such as Rett syndrome and Fragile X.

Webull offers Anavex Life Sciences Corp stock information, including NASDAQ: AVXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AVXL stock methods without spending real money on the virtual paper trading platform.